Opioid Use Disorder Among Clients of Community Mental Health Clinics: Prevalence, Characteristics, and Treatment Willingness.
Opioid Use Disorder Among Clients of Community Mental Health Clinics: Prevalence, Characteristics, and Treatment Willingness.
复制标题
DOI：
10.1176/appi.ps.202000818
复制
发表时间：
2022-03-01
期刊：
影响因子：
--
通讯作者：
Watkins KE
中科院分区：
文献类型：
--
作者：
Ober AJ;Hunter SB;McCullough CM;Leamon I;McCreary M;Beas I;Montero A;Tarn DM;Bromley E;Hurley B;Sheehe J;Martinez J;Watkins KE
本研究的目的是了解8个洛杉矶县精神卫生门诊诊所的客户中并发阿片类药物使用障碍的患病率和参与治疗的意愿。在两周的时间里，参加预约的成年人被问及是否愿意完成一项匿名健康调查。在过去一年中表明使用阿片类药物的客户被提供了一个更长的调查，以评估可能的阿片类药物使用障碍。接受药物治疗和接受任何治疗的意愿也被评估。3090名客户完成筛选。8%的人可能有处方（Rx）阿片类药物使用障碍；2%的人可能有海洛因使用障碍。Rx阿片类药物使用障碍患者中女性占52%，海洛因使用障碍患者中女性占30%。在Rx阿片类药物使用障碍患者中，43%为黑人，33%为西班牙裔，12%为白人；海洛因使用障碍患者中24%为黑人，22%为西班牙裔，39%为白人。与海洛因使用障碍患者相比，Rx阿片类药物使用障碍患者对阿片类药物使用障碍药物的熟悉程度较低（分别为81%和45%），接受治疗（分别为22%和41%）和服药（分别为18%和41%）的可能性较小。相信药物有助于停止阿片类药物的使用（β=13.54, p<0.01（丁丙诺啡））是药物服用意愿的最强预测因子；β= β=15.83, p< 0.01（长效注射纳曲酮）)研究结果强调，有必要识别阿片类药物使用障碍患者，并对心理健康机构的客户进行药物教育。
The goal of this study was to understand prevalence of co-occurring opioid use disorder and willingness to engage in treatment among clients of 8 Los Angeles County Department of Mental Health outpatient clinics. Adults presenting for an appointment over a 2-week period were asked if they would like to complete an anonymous health survey. Clients who indicated opioid use in the past year were offered a longer survey which assessed probable opioid use disorder. Willingness to take a medication and receive any treatment also were assessed. 3,090 clients completed screening. 8% had a probable prescription (Rx) opioid use disorder; 2% had a probable heroin use disorder. 52% with Rx opioid use disorder were female compared to 30% with heroin use disorder. Of those with Rx opioid use disorder, 43% were Black, 33% were Hispanic and 12% were White; of those with heroin use disorder 24% were Black, 22% were Hispanic, and 39% were White. Those with Rx opioid use disorder were less familiar with medications for opioid use disorder than those with heroin use disorder (81% and 45%, respectively), and less likely to have received treatment (22% and 41%, respectively) and to have taken medication (18% and 41%, respectively). The strongest predictor of willingness to take a medication was believing that it would help stop opioid use (β=13.54, p<0.01 (buprenorphine)); β= β=15.83, p<.01 (long-acting injectable naltrexone)). Findings highlight the need to identify people with opioid use disorder and educate clients in mental health settings about medications.
登录
查看更多内容
影响因子：
3.5
作者：
Friedmann PD;Hoskinson R;Gordon M;Schwartz R;Kinlock T;Knight K;Flynn PM;Welsh WN;Stein LA;Sacks S;O'Connell DJ;Knudsen HK;Shafer MS;Hall E;Frisman LK;Mat Working Group Of CJ-Dats
通讯作者：
Mat Working Group Of CJ-Dats
影响因子：
3.3
作者：
Christie-Mizell, C. Andre;Blount, Stacye A.;Vielehr, Peter S.
通讯作者：
Vielehr, Peter S.
影响因子：
1.9
作者：
Dickey, B;Dembling, B;Normand, SLT
通讯作者：
Normand, SLT
影响因子：
6.6
作者：
Feingold, Daniel;Brill, Silviu;Lev-Ran, Shaul
通讯作者：
Lev-Ran, Shaul
影响因子：
39.2
作者：
Han, Beth;Compton, Wilson M.;Jones, Christopher M.
通讯作者：
Jones, Christopher M.